Endometriosis
📧 Sign up to get email alerts when something new happens for Endometriosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: Prospective Study of the Outcomes of the Surgical Treatment of Deeply Infiltrating Endometriosis
This document provides an update on a prospective study evaluating the surgical treatment outcomes for deeply infiltrating endometriosis.
-
CLINICAL_TRIALS trial_result · 2012-04-26Clinical Trial Update: Letrozole in the Treatment of Severe and Recurrent Endometriosis [Phase 2]
Phase 2 trial update evaluating letrozole for the treatment of severe and recurrent endometriosis has completed.
-
FDA approval · 2012-03-19FDA Approved: DANAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for danazol from Teva Pharmaceuticals USA, Inc. The approval updates the drug's labeling and/or indi…
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: Pain Associated With Endometriosis [Phase 2]
Phase 2 clinical trial for pain associated with endometriosis has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: Endometriosis Trial: Study of NBI-56418 in Endometriosis [Phase 2]
Abbott's Phase 2 trial of NBI-56418 for endometriosis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-01-23FDA Approved: LUPRON DEPOT — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Lupron Depot (leuprolide acetate) from AbbVie, resulting in an updated approval and labeling for…
-
CLINICAL_TRIALS other · 2011-12-20Clinical Trial Update: Open Label of Thalidomide in Treatment of Women With Chronic Pelvic Pain Associated With Endometriosis [Phase 1]
An open-label Phase 1 trial of thalidomide for chronic pelvic pain in women with endometriosis has been terminated.
-
CLINICAL_TRIALS research · 2011-08-30Clinical Trial Update: The Impact of Surgical Treatment of Endometriomas on Ovarian Reserve [NA]
This clinical trial investigates how surgical treatment of ovarian endometriomas affects ovarian reserve, but the current status is unknown.
-
CLINICAL_TRIALS withdrawal · 2011-06-28Clinical Trial Update: The Immune Base of Endometriosis
The clinical trial investigating the immune basis of endometriosis, sponsored by Sheba Medical Center, has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: Comparison of Hemostatic Matrix and Bipolar Coagulation in Surgical Treatment of Endometriomas [NA]
The trial evaluated the use of a hemostatic matrix versus bipolar coagulation in the surgical treatment of endometriomas. The study status i…
-
FDA approval · 2011-06-14FDA Approved: LUPRON DEPOT — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for LUPRON DEPOT (leuprolide acetate) by AbbVie, expanding its approved indications and labeling.
-
CLINICAL_TRIALS research · 2011-05-10Clinical Trial Update: Endometrial Biopsy as Diagnostic Method for Endometriosis and Endometrioma
This clinical trial update describes evaluating endometrial biopsy as a diagnostic method for endometriosis and endometrioma in women underg…
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: Ear Electro-stimulation for Chronic Pelvic Pain [NA]
A Brigham and Women's Hospital study evaluating ear electro-stimulation for chronic pelvic pain in endometriosis has completed.
-
FDA approval · 2011-04-26FDA Approved: LEUPROLIDE ACETATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Leuprolide Acetate from Sun Pharmaceutical Industries, resulting in changes to the product's…
-
CLINICAL_TRIALS trial_result · 2011-04-13Clinical Trial Update: Efficacy of Letrozole and CC Alone in an IUI Program in Cases With Surgically Treated Minimal to Mild Endometriosis [NA]
Completed clinical trial evaluating letrozole and clomiphene citrate, used alone, in an intrauterine insemination program for women with sur…
-
FDA approval · 2011-04-08FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) filed by Uronova Pharmaceuticals. This action approves the supplem…
-
FDA label_change · 2011-04-08FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
The FDA approved a supplemental application for VABRINTY (leuprolide acetate) from URONOVA PHARMACEUTICALS, INC.
-
CLINICAL_TRIALS trial_result · 2011-04-06Clinical Trial Update: Pertubation With Lignocaine in Endometriosis [Phase 2]
Phase 2 clinical trial of lignocaine perturbation in endometriosis has completed, with assessment also addressing dysmenorrhea.
-
FDA approval · 2011-03-28FDA Approved: LEUPROLIDE ACETATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application from Sandoz Inc. for Leuprolide acetate (ANDA 074728).
-
CLINICAL_TRIALS research · 2011-03-15Clinical Trial Update: Randomized Study of Gonadotropin-releasing-hormone Agonist (GnRH-a) or Expectant Management for Endometriosis [Phase 4]
A Phase 4 randomized trial compares a gonadotropin-releasing-hormone agonist with expectant management for endometriosis; current status is …
-
CLINICAL_TRIALS trial_result · 2011-03-02Clinical Trial Update: The Effectiveness of Lng IUD for Treatment of the Patient Undergone Conservative Surgery for Pelvic Endometriosis [Phase 3]
Phase 3 trial assessing the effectiveness of the levonorgestrel-releasing intrauterine system (LNG-IUS) for endometriosis-related pelvic pai…
-
FDA label_change · 2011-01-14FDA Approved: ZOLADEX — Supplemental Application (TerSera Therapeutics LLC)
FDA approved a supplemental application for ZOLADEX (goserelin) from TerSera Therapeutics LLC. The approval includes changes to the product …
-
CLINICAL_TRIALS research · 2010-12-14Clinical Trial Update: Efficacy of Acupuncture on Chronic Pelvic Pain in Women With Endometriosis or Adenomyosis [NA]
An update on a clinical trial evaluating acupuncture for chronic pelvic pain in women with endometriosis or adenomyosis.
-
FDA approval · 2010-10-15FDA Approved: MEDROXYPROGESTERONE ACETATE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Medroxyprogesterone Acetate submitted by Prasco Laboratories.
-
FDA approval · 2010-10-05FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) by URONOVA PHARMACEUTICALS, INC.